Heart Transplant Research Today is a free monthly online journal that collates and summarizes the latest research about Heart Transplant, including details on risks, prognosis, procedure, surgery, organ donation.

Volume 6 (2010), Issue 1 (January)

1. Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients.
   J Immunol, 184(2): 624-36. [Abstract] [Full-text]
2. ATP-binding cassette subfamily B member 1 polymorphisms do not determine cyclosporin exposure, acute rejection or nephrotoxicity after heart transplantation.
   Transplantation, 89(1): 75-82. [Abstract] [Full-text]
3. Acute cardiac allograft rejection by directly cytotoxic CD4 T cells: parallel requirements for Fas and perforin.
   Transplantation, 89(1): 33-9. [Abstract] [Full-text]
4. Apollon/RNF41 myocardial messenger RNA diagnoses cardiac allograft apoptosis in rejection.
   Transplantation, 89(2): 245-52. [Abstract] [Full-text]
5. Heart transplantation in women with dilated cardiomyopathy.
   Transplantation, 89(2): 236-44. [Abstract] [Full-text]
6. Sildenafil citrate augments myocardial protection in heart transplantation.
   Transplantation, 89(2): 169-77. [Abstract] [Full-text]
7. Impact of abdominal complications on outcome after mechanical circulatory support.
   Ann Thorac Surg, 89(2): 522-8; discussion 528-9. [Abstract] [Full-text]

© 2005-2010 Heart Transplant Research Today. All Rights Reserved.